Results 141 to 150 of about 2,565 (197)

Microbiological treatment failure associated with macrolide-resistant <i>Bordetella pertussis</i>. [PDF]

open access: yesASM Case Rep
Prabhakar D   +10 more
europepmc   +1 more source

Immunodominance in Mouse and Human CD4+T-Cell Responses Specific for theBordetella pertussisVirulence Factor P.69 Pertactin

open access: green, 2008
Rachel M. Stenger   +10 more
openalex   +2 more sources

The Bordetella pertussis protein Pertactin: role in immunity and immune evasion

open access: yes, 2006
Pertussis is a highly contagious infectious disease of the respiratory tract which is caused by Bordetella pertussis. Before widespread introduction of vaccination against pertussis, almost every child contracted pertussis. The disease is most severe in neonates and children under the age of 1.
openaire   +1 more source

Antibody waning and Bordetella pertussis resurgence after the COVID-19 pandemic in the Netherlands. [PDF]

open access: yesNat Commun
Gaasbeek CM   +10 more
europepmc   +1 more source

Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024. [PDF]

open access: yesEuro Surveill
Miettinen M   +7 more
europepmc   +1 more source

Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections. [PDF]

open access: yesNPJ Vaccines
Da Costa RM   +4 more
europepmc   +1 more source

Mechanisms of natural and vaccine-induced immunity to Bordetella pertussis. [PDF]

open access: yesPLoS Pathog
Borkner L   +4 more
europepmc   +1 more source

Pulsed-Field Gel Electrophoresis, Pertactin, Pertussis Toxin S1 Subunit Polymorphisms, and Surfaceome Analysis of Vaccine and Clinical Bordetella pertussis Strains

open access: diamond, 2007
Daniela Bottero   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy